Total Payments
$2,357
2024 Payments
$99.33
Companies
22
Transactions
142
Medicare Patients
640
Medicare Billing
$142,379
Payment Breakdown by Category
Food & Beverage$2,297 (97.5%)
Education$59.98 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,297 | 140 | 97.5% |
| Education | $59.98 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $336.21 | 19 | $0 (2024) |
| Allergan, Inc. | $293.15 | 20 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $285.94 | 22 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $254.11 | 12 | $0 (2021) |
| ABBVIE INC. | $215.45 | 12 | $0 (2022) |
| ITI, Inc. | $171.73 | 9 | $0 (2022) |
| Lundbeck LLC | $125.69 | 8 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $115.40 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $105.54 | 2 | $0 (2021) |
| Shire North American Group Inc | $74.83 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.33 | 5 | Janssen Biotech, Inc. ($99.33) |
| 2023 | $80.60 | 4 | Janssen Biotech, Inc. ($80.60) |
| 2022 | $139.77 | 7 | ABBVIE INC. ($57.53) |
| 2021 | $646.58 | 39 | AbbVie Inc. ($157.92) |
| 2020 | $217.32 | 13 | ITI, Inc. ($58.10) |
| 2019 | $419.98 | 25 | Otsuka America Pharmaceutical, Inc. ($114.46) |
| 2018 | $340.88 | 21 | Allergan Inc. ($105.94) |
| 2017 | $412.97 | 28 | Sunovion Pharmaceuticals Inc. ($89.01) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 03/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Oncology | ||||||
| 02/08/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Oncology | ||||||
| 07/11/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Oncology | ||||||
| 03/27/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 03/06/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Oncology | ||||||
| 10/10/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Oncology | ||||||
| 08/10/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Oncology | ||||||
| 08/08/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Oncology | ||||||
| 02/23/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: PSYCHIATRY | ||||||
| 02/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/04/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Central Nervous System | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2021 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 142 | 372 | $56,695 | $20,243 |
| 2022 | 3 | 158 | 466 | $62,700 | $29,458 |
| 2021 | 2 | 152 | 708 | $91,920 | $46,006 |
| 2020 | 2 | 188 | 816 | $106,020 | $46,672 |
Total Patients
640
Total Services
2,362
Medicare Billing
$142,379
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 146 | $25,920 | $9,989 | 38.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 65 | 186 | $24,775 | $8,429 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 40 | $6,000 | $1,825 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 205 | $32,800 | $16,344 | 49.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 72 | 233 | $25,700 | $11,619 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 28 | $4,200 | $1,495 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 352 | $56,320 | $28,127 | 49.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 77 | 356 | $35,600 | $17,879 | 50.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 94 | 407 | $65,120 | $25,770 | 39.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 94 | 409 | $40,900 | $20,902 | 51.1% |
About Dr. William Mclarty, M.D
Dr. William Mclarty, M.D is a Psychiatry healthcare provider based in Smyrna, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114080520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Mclarty, M.D has received a total of $2,357 in payments from pharmaceutical and medical device companies, with $99.33 received in 2024. These payments were reported across 142 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,297).
As a Medicare-enrolled provider, Mclarty has provided services to 640 Medicare beneficiaries, totaling 2,362 services with total Medicare billing of $142,379. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Smyrna, GA
- Active Since 12/18/2006
- Last Updated 04/25/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114080520
Products in Payments
- VRAYLAR (Drug) $480.01
- REXULTI (Drug) $302.55
- CAPLYTA (Drug) $171.73
- DARZALEX (Biological) $149.88
- HETLIOZ (Drug) $148.52
- LATUDA (Drug) $115.40
- SPRAVATO (Drug) $94.44
- Trintellix (Drug) $94.07
- TRINTELLIX (Drug) $81.33
- Fanapt (Drug) $78.33
- IMBRUVICA (Drug) $71.63
- ERLEADA (Drug) $60.70
- TECVAYLI (Biological) $54.00
- MYDAYIS (Drug) $52.34
- NUEDEXTA (Drug) $40.32
- SUBOXONE SUBLINGUAL FILM (Drug) $35.86
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $34.64
- SUNOSI (Drug) $30.74
- VIIBRYD (Drug) $28.59
- FANAPT (Drug) $27.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Smyrna
Jeffrey Klopper, Md, MD
Psychiatry — Payments: $19,409
Psychiatry $19,409
Karl Mihalovits, Md, MD
Psychiatry — Payments: $10,826
Psychiatry $10,826
Dominic Nkwocha, Md, MD
Psychiatry — Payments: $4,824
Psychiatry $4,824
Dr. Gary Weichbrodt, M.d, M.D
Psychiatry — Payments: $3,342
Psychiatry $3,342
Hemachandra Gunawardhana, Md, MD
Psychiatry — Payments: $2,940
Psychiatry $2,940
Dr. Bharatkumar Patel, Md, MD
Psychiatry — Payments: $2,875
Psychiatry $2,875